Table 1

 Clinical and biological variables (median) in 15 patients at baseline, at weeks 6, 12 (with rosuvastatin), and at weeks 18, 24 (without rosuvastatin)

VariableBaselineWith rosuvastatinAfter stopping rosuvastatin
At 6 weeksAt 12 weeksAt 18 weeksAt 24 weeks
*Significant changes compared with baseline (Wilcoxon’s signed ranks test), p⩽0.05; **significant changes compared with 12 weeks (Wilcoxon’s signed rank test), p⩽0.05.
ESR (mm/1st h)22.020.015.0*18.015.0
CRP (log mg/l)15.010.010.0*12.512.0
Total cholesterol (mmol/l)4.83.5*3.6*5.0**5.0**
HDL-cholesterol (mmol/l)1.31.31.51.31.2
LDL-cholesterol (mmol/l)2.81.1*1.8*3.3**3.2**
Triglycerides (mmol/l)1.41.21.31.51.8
BASDAI6.35.65.85.25.6
BASFI4.75.44.95.04.9
BASMI4.44.03.83.64.2
General wellbeing according to doctor4.44.53.94.24.0
General wellbeing according to patient6.45.75.35.65.7
Pain score6.56.86.25.75.2